ABSTRACT
BACKGROUND: Hyperkalemia is a common complication in cardiorenal patients treated with agents interfering with renal potassium (K+) excretion. It frequently leads to discontinuation of potentially life-saving medication, which has increased the importance of K+ monitoring. Non-invasive means to detect hyperkalemia are currently unavailable, but would be of potential use for therapy guidance. The aim of the present study was to assess the analytical performance of genetically encoded potassium-ion indicators (GEPIIs) in measuring salivary [K+] ([K+]Saliva) and to determine whether changes of [K+]Saliva depict those of [K+]Plasma. METHODS: We conducted this proof-of-concept study: saliva samples from 20 healthy volunteers as well as plasma and saliva from 29 patients on hemodialysis (HD) before and after three consecutive HD treatments were collected. We compared [K+]Saliva as assessed by the gold standard ion-selective electrode (ISE) with GEPII measurements. RESULTS: The Bland-Altmann analysis showed a strong agreement (bias 0.71; 95% limits of agreement from -2.79 to 4.40) between GEPII and ISE. Before treatment, patients on HD showed significantly higher [K+]Saliva compared with healthy controls [median 37.7 (30.85; 48.46) vs 23.8 (21.63; 25.23) mmol/L; P < .05]. [K+]Plasma in HD patients decreased significantly after dialysis. This was paralleled by a significant decrease in [K+]Saliva, and both parameters increased until the subsequent HD session. Despite similar kinetics, we found weak or no correlation between [K+]Plasma and [K+]Saliva. CONCLUSION: GEPIIs have shown an excellent performance in determining [K+]Saliva. [K+]Plasma and [K+]Saliva exhibited similar kinetics. To determine whether saliva could be a suitable sample type to monitor [K+]Plasma, further testing in future studies are required.
Subject(s)
Hyperkalemia , Potassium , Humans , Renal Dialysis , Kidney , Plasma/chemistryABSTRACT
According to genome-wide RNA sequencing data from human and mouse platelets, adipose triglyceride lipase (ATGL), the main lipase catalyzing triglyceride (TG) hydrolysis in cytosolic lipid droplets (LD) at neutral pH, is expressed in platelets. Currently, it is elusive to whether common lipolytic enzymes are involved in the degradation of TG in platelets. Since the consequences of ATGL deficiency in platelets are unknown, we used whole-body and platelet-specific (plat)Atgl-deficient (-/-) mice to investigate the loss of ATGL on platelet function. Our results showed that platelets accumulate only a few LD due to lack of ATGL. Stimulation with platelet-activating agonists resulted in comparable platelet activation in Atgl-/-, platAtgl-/-, and wild-type mice. Measurement of mitochondrial respiration revealed a decreased oxygen consumption rate in platelets from Atgl-/- but not from platAtgl-/- mice. Of note, global loss of ATGL was associated with an anti-thrombogenic phenotype, which was evident by reduced thrombus formation in collagen-coated channels in vitro despite unchanged bleeding and occlusion times in vivo. We conclude that genetic deletion of ATGL affects collagen-induced thrombosis without pathological bleeding and platelet activation.
Subject(s)
Acyltransferases/metabolism , Lipase , Thrombosis , Animals , Lipase/metabolism , Mice , Mice, Knockout , Platelet Activation , Triglycerides/metabolismABSTRACT
Heart failure with preserved ejection fraction (HFpEF) is a major health problem without effective therapies. This study assessed the effects of histone deacetylase (HDAC) inhibition on cardiopulmonary structure, function, and metabolism in a large mammalian model of pressure overload recapitulating features of diastolic dysfunction common to human HFpEF. Male domestic short-hair felines (n = 31, aged 2 months) underwent a sham procedure (n = 10) or loose aortic banding (n = 21), resulting in slow-progressive pressure overload. Two months after banding, animals were treated daily with suberoylanilide hydroxamic acid (b + SAHA, 10 mg/kg, n = 8), a Food and Drug Administration-approved pan-HDAC inhibitor, or vehicle (b + veh, n = 8) for 2 months. Echocardiography at 4 months after banding revealed that b + SAHA animals had significantly reduced left ventricular hypertrophy (LVH) (P < 0.0001) and left atrium size (P < 0.0001) versus b + veh animals. Left ventricular (LV) end-diastolic pressure and mean pulmonary arterial pressure were significantly reduced in b + SAHA (P < 0.01) versus b + veh. SAHA increased myofibril relaxation ex vivo, which correlated with in vivo improvements of LV relaxation. Furthermore, SAHA treatment preserved lung structure, compliance, blood oxygenation, and reduced perivascular fluid cuffs around extra-alveolar vessels, suggesting attenuated alveolar capillary stress failure. Acetylation proteomics revealed that SAHA altered lysine acetylation of mitochondrial metabolic enzymes. These results suggest that acetylation defects in hypertrophic stress can be reversed by HDAC inhibitors, with implications for improving cardiac structure and function in patients.
Subject(s)
Diastole , Heart Failure/drug therapy , Heart Failure/physiopathology , Histone Deacetylase Inhibitors/therapeutic use , Animals , Blood Pressure/drug effects , Cats , Diastole/drug effects , Disease Models, Animal , Heart Ventricles/drug effects , Heart Ventricles/physiopathology , Histone Deacetylase Inhibitors/pharmacology , Lung/drug effects , Lung/pathology , Lung/physiopathology , Male , Mitochondria/drug effects , Mitochondria/metabolism , Muscle Fibers, Skeletal/drug effects , Muscle Fibers, Skeletal/pathology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Myofibrils/drug effects , Myofibrils/metabolism , Phenotype , Protein Processing, Post-Translational/drug effects , Stroke Volume/drug effects , Vorinostat/pharmacology , Vorinostat/therapeutic useABSTRACT
The development of so-called Proticles opens attractive possibilities for new drug delivery systems. Proticles are nanoparticles (NPs), which are formed by self-assembly of negatively charged oligonucleotides in combination with the positively charged peptide protamine. Polyethylene glycol (PEG) is a widely known pharmaceutical agent to stop particle growth and prolong circulation half-life of drug delivery systems. Therefore, two different NP formulations - one PEGylated and one non-PEGylated - were used in this work to gain information about the biological stability and half-life in circulation of Proticles. Thus, this study presents data of in vitro stability and in vivo pharmacokinetics of both, non-PEGylated and PEGylated Proticles radiolabeled with 111InCl3. The study demonstrated that successful radiolabeling of both Proticle-formulations was performed resulting in high radiochemical yields (> 85 %). Furthermore, the influence of PEGylation on the in vitro stability of 111In-radiolabeled NPs was investigated. No significant difference due to PEGylation was found. Unlike in vitro results, non-PEGylated 111In-Proticles seemed to degrade faster in vivo than PEGylated 111In-proticles, resulting in significantly higher blood values (111In-PEG-proticles: 0.23⯱â¯0.01 % ID/g 1â¯h p.i.; 111In-proticles: 0.06⯱â¯0.01 % ID/g 1â¯h p.i.; pâ¯<â¯0.05). Visualized by SPECT imaging urinary excretion represented the major pathway of elimination for both NP-formulations. In conclusion, this study provides data indicating a positive influence of PEG-derivatization on the biodistribution and pharmacokinetics of Proticles. These results form the basis for further developments as drug delivery and active drug targeting devices.
Subject(s)
Nanoparticles , Oligonucleotides/pharmacokinetics , Polyethylene Glycols/pharmacokinetics , Protamines/pharmacokinetics , Animals , Drug Delivery Systems , Female , Half-Life , Nanoparticles/chemistry , Oligonucleotides/chemistry , Polyethylene Glycols/chemistry , Protamines/chemistry , Rats, Inbred Lew , Tissue DistributionABSTRACT
Nitric Oxide (NOâ¢) is a small radical, which mediates multiple important cellular functions in mammals, bacteria and plants. Despite the existence of a large number of methods for detecting NO⢠in vivo and in vitro, the real-time monitoring of NO⢠at the single-cell level is very challenging. The physiological or pathological effects of NO⢠are determined by the actual concentration and dwell time of this radical. Accordingly, methods that allow the single-cell detection of NO⢠are highly desirable. Recently, we expanded the pallet of NO⢠indicators by introducing single fluorescent protein-based genetically encoded nitric oxide (NOâ¢) probes (geNOps) that directly respond to cellular NO⢠fluctuations and, hence, addresses this need. Here we demonstrate the usage of geNOps to assess intracellular NO⢠signals in response to two different chemical NOâ¢-liberating molecules. Our results also confirm that freshly prepared 3-(2-hydroxy-1-methyl-2-nitrosohydrazino)-N-methyl-1-propanamine (NOC-7) has a much higher potential to evoke change in intracellular NO⢠levels as compared with the inorganic NO⢠donor sodium nitroprusside (SNP). Furthermore, dual-color live-cell imaging using the green geNOps (G-geNOp) and the chemical Ca2+ indicator fura-2 was performed to visualize the tight regulation of Ca2+-dependent NO⢠formation in single endothelial cells. These representative experiments demonstrate that geNOps are suitable tools to investigate the real-time generation and degradation of single-cell NO⢠signals in diverse experimental setups.
Subject(s)
Endothelial Cells/metabolism , Fluorescent Dyes/metabolism , Nitric Oxide/metabolism , Animals , Cells, Cultured , Dependovirus , Fura-2/chemistry , Genetic Vectors , HEK293 Cells , Humans , Hydrazines/pharmacology , Microscopy, Fluorescence/methods , Nitric Oxide Donors/pharmacology , Nitroprusside/pharmacology , Parvovirinae/geneticsABSTRACT
Nitric oxide () is a free radical with a wide range of biological effects, but practically impossible to visualize in single cells. Here we report the development of novel multicoloured fluorescent quenching-based probes by fusing a bacteria-derived -binding domain close to distinct fluorescent protein variants. These genetically encoded probes, referred to as geNOps, provide a selective, specific and real-time read-out of cellular dynamics and, hence, open a new era of bioimaging. The combination of geNOps with a Ca(2+) sensor allowed us to visualize and Ca(2+) signals simultaneously in single endothelial cells. Moreover, targeting of the probes was used to detect signals within mitochondria. The geNOps are useful new tools to further investigate and understand the complex patterns of signalling on the single (sub)cellular level.
Subject(s)
Endothelial Cells/metabolism , Fluorescent Dyes/metabolism , Mitochondria/metabolism , Myocytes, Cardiac/metabolism , Nitric Oxide/metabolism , Animals , Bacterial Proteins/metabolism , Calcium Signaling , Chick Embryo , Green Fluorescent Proteins/metabolism , HeLa Cells , Heart Ventricles/cytology , Humans , Luminescent Proteins/metabolism , Signal TransductionABSTRACT
Cameleons are sophisticated genetically encoded fluorescent probes that allow quantifying cellular Ca2+ signals. The probes are based on Förster resonance energy transfer (FRET) between terminally located fluorescent proteins (FPs), which move together upon binding of Ca2+ to the central calmodulin myosin light chain kinase M13 domain. Most of the available cameleons consist of cyan and yellow FPs (CFP and YFP) as the FRET pair. However, red-shifted versions with green and orange or red FPs (GFP, OFP, RFP) have some advantages such as less phototoxicity and minimal spectral overlay with autofluorescence of cells and fura-2, a prominent chemical Ca2+ indicator. While GFP/OFP- or GFP/RFP-based cameleons have been successfully used to study cytosolic and mitochondrial Ca2+ signals, red-shifted cameleons to visualize Ca2+ dynamics of the endoplasmic reticulum (ER) have not been developed so far. In this study, we generated and tested several ER targeted red-shifted cameleons. Our results show that GFP/OFP-based cameleons due to miss-targeting and their high Ca2+ binding affinity are inappropriate to record ER Ca2+ signals. However, ER targeted GFP/RFP-based probes were suitable to sense ER Ca2+ in a reliable manner. With this study we increased the palette of cameleons for visualizing Ca2+ dynamics within the main intracellular Ca2+ store.
Subject(s)
Calcium/analysis , Calcium/chemistry , Endoplasmic Reticulum/chemistry , Fluorescent Dyes/chemistry , Luminescent Proteins/chemistry , Calcium/metabolism , Endoplasmic Reticulum/metabolism , Fluorescence Resonance Energy Transfer , Fluorescent Dyes/metabolism , HEK293 Cells , HeLa Cells , Humans , Luminescent Proteins/metabolism , Microscopy, ConfocalABSTRACT
Mitochondria contribute to cell signaling by controlling store-operated Ca(2+) entry (SOCE). SOCE is activated by Ca(2+) release from the endoplasmic reticulum (ER), whereupon stromal interacting molecule 1 (STIM1) forms oligomers, redistributes to ER-plasma-membrane junctions and opens plasma membrane Ca(2+) channels. The mechanisms by which mitochondria interfere with the complex process of SOCE are insufficiently clarified. In this study, we used an shRNA approach to investigate the direct involvement of mitochondrial Ca(2+) buffering in SOCE. We demonstrate that knockdown of either of two proteins that are essential for mitochondrial Ca(2+) uptake, the mitochondrial calcium uniporter (MCU) or uncoupling protein 2 (UCP2), results in decelerated STIM1 oligomerization and impaired SOCE following cell stimulation with an inositol-1,4,5-trisphosphate (IP3)-generating agonist. Upon artificially augmented cytosolic Ca(2+) buffering or ER Ca(2+) depletion by sarcoplasmic or endoplasmic reticulum Ca(2+)-ATPase (SERCA) inhibitors, STIM1 oligomerization did not rely on intact mitochondrial Ca(2+) uptake. However, MCU-dependent mitochondrial sequestration of Ca(2+) entering through the SOCE pathway was essential to prevent slow deactivation of SOCE. Our findings show a stimulus-specific contribution of mitochondrial Ca(2+) uptake to the SOCE machinery, likely through a role in shaping cytosolic Ca(2+) micro-domains.
Subject(s)
Calcium Channels/metabolism , Calcium Signaling , Calcium/metabolism , Inositol 1,4,5-Trisphosphate/metabolism , Membrane Proteins/metabolism , Mitochondria/metabolism , Neoplasm Proteins/metabolism , Calcium Channels/genetics , HeLa Cells , Humans , Inositol 1,4,5-Trisphosphate/genetics , Membrane Proteins/genetics , Neoplasm Proteins/genetics , Stromal Interaction Molecule 1ABSTRACT
PURPOSE: To compare visual outcome and manual handling of additional multifocal sulcus-fixated intraocular lenses (IOLs) of different materials and lens concepts. METHODS: Visual outcomes after implantation of a monofocal IOL in the capsular bag followed by implantation of a sulcus-fixated multifocal IOL (MIOL) in patients with cataract were assessed. Patients were randomly assigned to receive either the refractive Sulcoflex 653F (Rayner Surgical GmbH, Bamberg, Germany) (35 eyes) or the diffractive MS 714 PB Diff (Dr. Schmidt Intraocularlinsen GmbH, St. Augustin, Germany) (33 eyes) additional MIOL. Three months postoperatively, visual acuity at far, intermediate, and near distance and contrast sensitivity under different conditions were evaluated. Patients with binocular implantation were asked to rate their subjective quality of vision. RESULTS: No complications occurred during or after surgery. No significant differences in uncorrected and corrected distance visual acuity at all distances were found between groups. All eyes achieved uncorrected visual acuity of 0.3 logMAR (20/40 Snellen) or better at all distances. Contrast sensitivity was significantly better in the diffractive MS 714 PB Diff group than in the refractive Sulcoflex 653F group under all conditions. The refractive Sulcoflex 653F group experienced more photic phenomena (81%) than the diffractive MS 714 PB Diff group (25%), but the disturbances were scored as mild to moderate in most cases (93%/100%). The unfolding procedure of the acrylic Sulcoflex 653F IOL was smoother and more controllable than that of the silicone MS 714 PB Diff IOL. CONCLUSIONS: Both additional MIOLs performed well in terms of far, intermediate, and near vision and enabled patients to handle almost all areas of activity without glasses.
Subject(s)
Acrylic Resins , Lens Implantation, Intraocular , Lenses, Intraocular , Phacoemulsification , Pseudophakia/physiopathology , Silicones , Visual Acuity/physiology , Aged , Aged, 80 and over , Contrast Sensitivity/physiology , Female , Humans , Male , Middle Aged , Prospective Studies , Refraction, Ocular/physiology , Vision, Binocular/physiologyABSTRACT
BACKGROUND: Disorders in wound healing (DWH) are common in trauma patients, the reasons being not completely understood. Inadequate nutritional status may favor DWH, partly by means of oxidative stress. Reliable data, however, are lacking. This study should investigate the status of extracellular micronutrients in patients with DWH within routine setting. METHODS: Within a cross-sectional study, the plasma/serum status of several micronutrients (retinol, ascorbic acid, 25-hydroxycholecalciferol, α-tocopherol, ß-carotene, selenium, and zinc) were determined in 44 trauma patients with DWH in addition to selected proteins (albumin, prealbumin, and C-reactive protein; CRP) and markers of pro-/antioxidant balance (antioxidant capacity, peroxides, and malondialdehyde). Values were compared to reference values to calculate the prevalence for biochemical deficiency. Correlations between CRP, albumin and prealbumin, and selected micronutrients were analyzed by Pearson's test. Statistical significance was set at P < 0.05. RESULTS: Mean concentrations of ascorbic acid (23.1 ± 15.9 µmol/L), 25-hydroxycholecalciferol (46.2±30.6 nmol/L), ß-carotene (0.6 ± 0.4 µmol/L), selenium (0.79±0.19 µmol/L), and prealbumin (24.8 ± 8.2 mg/dL) were relatively low. Most patients showed levels of ascorbic acid (<28 µmol/L; 64%), 25-hydroxycholecalciferol (<50 µmol/L; 59%), selenium (≤ 94 µmol/L; 71%) and ß-carotene (<0.9 µmol/L; 86%) below the reference range. Albumin and prealbumin were in the lower normal range and CRP was mostly above the reference range. Plasma antioxidant capacity was decreased, whereas peroxides and malondialdehyde were increased compared to normal values. Inverse correlations were found between CRP and albumin (P < 0.05) and between CRP and prealbumin (P < 0.01). Retinol (P < 0.001), ascorbic acid (P < 0.01), zinc (P < 0.001), and selenium (P < 0.001) were negatively correlated with CRP. CONCLUSIONS: Trauma patients with DWH frequently suffer from protein malnutrition and reduced plasma concentrations of several micronutrients probably due to inflammation, increased requirement, and oxidative burden. Thus, adequate nutritional measures are strongly recommended to trauma patients.
Subject(s)
Antioxidants/metabolism , Micronutrients/blood , Wound Healing , Wounds and Injuries/blood , Wounds and Injuries/therapy , Adult , Aged , Aged, 80 and over , Anthropometry , Ascorbic Acid/blood , Biomarkers/blood , C-Reactive Protein/metabolism , Calcifediol/blood , Cross-Sectional Studies , Female , Humans , Male , Malnutrition/blood , Malnutrition/physiopathology , Malondialdehyde/blood , Middle Aged , Nutritional Status , Oxidative Stress/drug effects , Selenium/blood , Vitamin A/blood , Zinc/blood , alpha-Tocopherol/blood , beta Carotene/bloodABSTRACT
BACKGROUND & AIMS: : We hypothesize that wound closure in trauma patients with disorders in wound healing is accelerated by supplementation of antioxidant micronutrients and glutamine. METHODS: In a randomized, double-blind, placebo-controlled trial, 20 trauma patients with disorders in wound healing were orally supplemented with antioxidant micronutrients (ascorbic acid, α-tocopherol, ß-carotene, zinc, selenium) and glutamine (verum) or they received isoenergetic amounts of maltodextrine (placebo) for 14 days. Plasma/serum levels of micronutrients, glutamine, and vascular endothelial growth factor-A (VEGF-A) were determined before and after supplementation. In the wound, several parameters of microcirculation were measured. Time from study entry to wound closure was recorded. RESULTS: Micronutrients in plasma/serum did not change except for selenium which increased in the verum group (1.1 ± 0.2 vs. 1.4 ± 0.2 µmol/l; P = 0.009). Glutamine decreased only in the placebo group (562 ± 68 vs. 526 ± 55 µmol/l; P = 0.047). The prevalence of hypovitaminoses and the concentration of VEGF-A did not change. Considering microcirculation, only O(2)-saturation decreased in the placebo group (56.7 ± 23.4 vs. 44.0 ± 24.0 [arbitrary units]; P = 0.043). Wound closure occurred more rapidly in the verum than in the placebo group (35 ± 22 vs. 70 ± 35 d; P = 0.01). CONCLUSIONS: Time to wound closure can be shortened by oral antioxidant and glutamine containing supplements in trauma patients with disorders in wound healing.